Skip to main content
Back to Lightspeed Venture Partners

Lightspeed Venture Partners's Therapeutics Portfolio

Browse 12 Therapeutics companies funded by Lightspeed Venture Partners. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
12
Total Funding in Therapeutics
$2.1B

Therapeutics Portfolio Companies (12)

Export
BiotechnologyMedicalTherapeutics

Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.

Cambridge, United States
August 2024
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Boston, United States
May 2026
$25.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyEdiscoveryHealth CareLife ScienceManufacturingTherapeutics

Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.

Boston, United States
May 2025
$177.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareTherapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

South San Francisco, United States
April 2024
$1.0B
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Enlaza Therapeutics is a biotechnology research company.

La Jolla, United States
September 2025
$15.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

London, United Kingdom
May 2024
$120.0M
Series B

Founder Contacts

30,000+ verified contacts

Clinical TrialsHealth CareMedical DeviceTherapeutics

Developed the first FDA-cleared digital therapeutic that significantly reduces/eliminates symptoms of panic attacks & PTSD in only 28 days

Kirkland, United States
April 2024
$22.6M
Series E

Founder Contacts

30,000+ verified contacts

Health CareMental HealthMobile AppsPersonal HealthTherapeutics

Daybreak Health specializes in providing online counseling services, especially for teens, helping to stabilize their mental fitness.

San Francisco, United States
August 2023
$13.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedicalTherapeutics

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Watertown, United States
January 2026
$125.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Lexington, United States
December 2025
$120.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.

San Diego, United States
December 2025
$130.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

Redwood City, United States
November 2025
$350.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

Explore Lightspeed Venture Partners's Full Portfolio

View all companies funded by Lightspeed Venture Partners across every industry and funding stage.

View Full Lightspeed Venture Partners Portfolio